510(k) K253069

Lipoprotein (a) Molarity Assay by Diazyme Laboratories, Inc. — Product Code DFC

K253069 is an FDA 510(k) premarket notification submitted by Diazyme Laboratories, Inc. for the device "Lipoprotein (a) Molarity Assay". The FDA issued a decision of Substantially Equivalent on Jun 16, 2026. The device falls under product code DFC (Lipoprotein, Low-Density, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5600. Diazyme Laboratories, Inc. has 51 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jun 16, 2026
Date Received
Sep 23, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Lipoprotein, Low-Density, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5600
Review Panel
IM
Submission Type
510(k)

Need the full FDA record for Diazyme Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K253069. Report a data issue: hello@regdatalab.com.